Novartis reveals drop in net profit

Swiss drug maker Novartis AG said its fourth-quarter net profit fell 47% to 1.21 billion US dollars.

Novartis reveals drop in net profit

Swiss drug maker Novartis AG said its fourth-quarter net profit fell 47% to 1.21 billion US dollars.

The Basel-based company said today that its results were affected by the decision to end a clinical study into wider uses of the hypertension drug Tekturna and other charges.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited